NCT01504412View on ClinicalTrials.gov

Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral Neuropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
PainDiabetic Peripheral Neuropathy
Interventions
DRUG

DS-5565

Oral tablets administered twice daily

DRUG

DS-5565

Oral tablets administered twice daily

DRUG

DS-5565

Oral tablets administered twice daily

DRUG

Placebo

DS-5565 placebo oral tablets and pregabalin placebo oral capsules administered 2 times per day

DRUG

Pregabalin capsules

Pregabalin oral capsules 150 mg administered twice a day

Trial Locations (3)

Unknown

Tokyo

Seoul

Taipei

Sponsors
All Listed Sponsors
lead

Daiichi Sankyo Co., Ltd.

INDUSTRY

NCT01504412 - Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral Neuropathy | Biotech Hunter | Biotech Hunter